[Change of serum immunoglobulin level in patients with diffuse large B cell lymphoma after rituximab combined with chemotherapy].

Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology

Volumn 19, Issue 3, 2011, Pages 676-679

  Wang, Quan Shun ^a   Zhao, Y ^b   Wang, Shu Hong ^b   Li, Hong Hua ^b   Huang, Wen Rong ^b   Gao, Chun Ji ^b   Yu, L ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; PREDNISONE; RITUXIMAB; VINCRISTINE;

ARTICLE; BLOOD; HUMAN; IMMUNOLOGY; LARGE CELL LYMPHOMA; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; HUMANS; IMMUNOGLOBULINS; LYMPHOMA, LARGE B-CELL, DIFFUSE; PREDNISONE; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VINCRISTINE;

EID: 84874660039     PISSN: 10092137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)